116 related articles for article (PubMed ID: 14623174)
1. Inhibitory effects and spectral interactions of isomeric methoxyindazoles on recombinant nitric oxide synthases.
Tuynman A; Pérollier C; Frapart Y; Schumann-Bard P; Collot V; Rault S; Boucher JL
Nitric Oxide; 2003 Sep; 9(2):86-94. PubMed ID: 14623174
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of a series of 7-substituted-indazoles toward nitric oxide synthases: particular potency of 1H-indazole-7-carbonitrile.
Cottyn B; Acher F; Ramassamy B; Alvey L; Lepoivre M; Frapart Y; Stuehr D; Mansuy D; Boucher JL; Vichard D
Bioorg Med Chem; 2008 Jun; 16(11):5962-73. PubMed ID: 18502134
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of the constitutive and inducible nitric oxide synthase isoforms by indazole agents.
Wolff DJ; Gribin BJ
Arch Biochem Biophys; 1994 Jun; 311(2):300-6. PubMed ID: 7515613
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles.
Schumann P; Collot V; Hommet Y; Gsell W; Dauphin F; Sopkova J; MacKenzie ET; Duval D; Boulouard M; Rault S
Bioorg Med Chem Lett; 2001 May; 11(9):1153-6. PubMed ID: 11354365
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of inhibition of porcine brain nitric oxide synthase by the antinociceptive drug 7-nitro-indazole.
Mayer B; Klatt P; Werner ER; Schmidt K
Neuropharmacology; 1994 Nov; 33(11):1253-9. PubMed ID: 7532811
[TBL] [Abstract][Full Text] [Related]
7. Alternative nitric oxide-producing substrates for NO synthases.
Mansuy D; Boucher JL
Free Radic Biol Med; 2004 Oct; 37(8):1105-21. PubMed ID: 15451052
[TBL] [Abstract][Full Text] [Related]
8. Electron transfer and catalytic activity of nitric oxide synthases. Chimeric constructs of the neuronal, inducible, and endothelial isoforms.
Nishida CR; Ortiz de Montellano PR
J Biol Chem; 1998 Mar; 273(10):5566-71. PubMed ID: 9488682
[TBL] [Abstract][Full Text] [Related]
9. Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug.
Ask K; Dijols S; Giroud C; Casse L; Frapart YM; Sari MA; Kim KS; Stuehr DJ; Mansuy D; Camus P; Boucher JL
Chem Res Toxicol; 2003 Dec; 16(12):1547-54. PubMed ID: 14680368
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents.
Wolff DJ; Lubeskie A; Umansky S
Arch Biochem Biophys; 1994 Nov; 314(2):360-6. PubMed ID: 7526799
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
12. Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay.
Alderton WK; Boyhan A; Lowe PN
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):195-201. PubMed ID: 9576868
[TBL] [Abstract][Full Text] [Related]
13. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms.
Southan GJ; Szabó C
Biochem Pharmacol; 1996 Feb; 51(4):383-94. PubMed ID: 8619882
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nitric-oxide synthase by nicotine.
Tonnessen BH; Severson SR; Hurt RD; Miller VM
J Pharmacol Exp Ther; 2000 Nov; 295(2):601-6. PubMed ID: 11046094
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of neuronal nitric oxide synthase by 4-amino pteridine derivatives: structure-activity relationship of antagonists of (6R)-5,6,7,8-tetrahydrobiopterin cofactor.
Fröhlich LG; Kotsonis P; Traub H; Taghavi-Moghadam S; Al-Masoudi N; Hofmann H; Strobel H; Matter H; Pfleiderer W; Schmidt HH
J Med Chem; 1999 Oct; 42(20):4108-21. PubMed ID: 10514281
[TBL] [Abstract][Full Text] [Related]
17. Two modes of binding of N-hydroxyguanidines to NO synthases: first evidence for the formation of iron-N-hydroxyguanidine complexes and key role of tetrahydrobiopterin in determining the binding mode.
Lefèvre-Groboillot D; Frapart Y; Desbois A; Zimmermann JL; Boucher JL; Gorren AC; Mayer B; Stuehr DJ; Mansuy D
Biochemistry; 2003 Apr; 42(13):3858-67. PubMed ID: 12667076
[TBL] [Abstract][Full Text] [Related]
18. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
Babu BR; Griffith OW
J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
[TBL] [Abstract][Full Text] [Related]
19. Reduction of quinonoid dihydrobiopterin to tetrahydrobiopterin by nitric oxide synthase.
Witteveen CF; Giovanelli J; Kaufman S
J Biol Chem; 1996 Feb; 271(8):4143-7. PubMed ID: 8626754
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
